Topical mometasone furoate for vulvar lichen sclerosus

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 6, 2003, Pages 444-448

  Cattaneo, Antonio ^a   De Magnis, Angelina ^b   Botti, Elena ^b   Sonni, Lorella ^b   Carli, Paolo ^b   Taddei, Gian Luigi ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Clobetasol; Lichen sclerosus; Mometasone furoate; Vulvar diseases

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BECLOMETASONE; CLOBETASOL PROPIONATE; EMOLLIENT AGENT; ESTROGEN; GLUCOCORTICOID; HYDROCORTISONE; MOMETASONE FUROATE; PROGESTERONE; RETINOID; STEROID; TESTOSTERONE;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTACT DERMATITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ROSACEA; SKIN ATROPHY; VULVA DISEASE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; PREGNADIENEDIOLS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VULVAR DISEASES;

EID: 0038310648     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Friedrich EG: Vulvar dystrophy. Clin Obstet Gynecol 1985;28:178-187
2. Soper JT, Creasman WT: Vulvar dystrophies. Clin Obstet Gynecol 1986;29:431-439
3. Cattaneo A, Bracco GL, Maestrini G, et al: Lichen sclerosus and squamous hyperplasia of the vulva: A clinical study of medical treatment. J Reprod Med 1991;36:301-305
4. Ridley CM: General dermatological conditions and dermatoses of the vulva. In The Vulva. Edited by CM Ridley. Edinburgh, Churchill Livingstone, 1988, pp 172-188
5. Virgili A, Corazza M, Bianchi A, et al: Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. J Reprod Med 1995;40:614-618
6. Carli P, Cattaneo A, Pimpinelli N, et al: Immunohistochemical evidence of skin immunosystem involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991;182:18-22
7. Carli P, Bracco GL, Taddei GL, et al: Vulvar lichen sclerosus: Immunohistologic evaluation before and after therapy. J Reprod Med 1994;39:110-114
8. Carli P, Cattaneo A, Giannotti B: Clobetasol propionate 0.05% cream in the treatment of vulval lichen sclerosus: Effect on the immunohistological profile. Br J Dermatol 1992;127:542-543
9. Dalziel KL, Millard PR, Woinarowska F: The treatment of vulval lichen sclerosus with a potent topical steroid (clobetasol propionate 0.05% cream). Br J Dermatol 1991;124:461-464
10. Dalziel KL, Woinarowska F: Long term control of vulvar lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993;38:25-27
11. Bracco GL, Carli P, Sonni L, et al: Clinical and histologic effects of topical treatment of vulval lichen sclerosus: A critical evaluation. J Reprod Med 1993;38:37-40
12. Cattaneo A, Carli P, De Marco A, et al: Testosterone maintenance therapy: Effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996;41:99-102
13. Prakash A, Benfield P: Topical mometasone: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998;55:145-163
14. Farrel AM, Marren P, Dean D, et al: Lichen sclerosus: Evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999;140:1087-1092
15. Friedman M, Weissman A, Kerner H, et al: Vulvar lichen sclerosus treated with super potent topical corticosteroid (clobetasol propionate 0.05%). Cervix 1994;12:21-24
16. Lorenz B, Kaufman RH, Kutzner SK: Lichen sclerosus therapy with clobetasol propionate. J Reprod Med 1998;43:790-794
17. Sideri M, Origoni M, Spinaci L, et al: Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994;46:53-56
18. Carruthers JA, August PS, Stoughton RB: Observations on the systemics effect of topical clobetasol propionate. Br Med J 1975;4:203-204
19. Zorlu CG, Cobanoglu T: Medical treatment of squamous hyperplasia and lichen sclerosus of the vulva. Int J Gynaecol Obstet 1995;51:235-238
20. Paslin D: Androgens in the topical treatment of lichen sclerosus. Int J Dermatol 1996;35:298-301
21. Shohat M, Mimouni M, Shuper A: Adrenocortical suppression by topical application of glucocorticosteroids in infants with seborrheic dermatitis. Clin Pediatr 1986;25:209-212
22. Tosti A, Guerra L, Manuzzi P, et al: Contact dermatitis from clobetasol propionate. Contact Dermatitis 1987;17:256-257
23. Korting HC, Kerscher MJ, Schafer-Korting M: Topical glucocorticoids with improved benefit/risk ratio: Do they exist? J Am Acad Dermatol 1992;27:87-92
24. McKay M, Chanco Turner ML: Topical steroids in vulvar disease: Benefits and risks. Poster presentation, XVth World Congress of the International Society for the Study of Vulvo-vaginal Disease, Santa Fe, September 26-30, 1999
25. Carli P, Cattaneo A, De Magnis A, et al: Squamous cell carcinoma arising in vulval lichen sclerosus: A longitudinal cohort study. Eur J Cancer Prev 1995;4:491-495